LENSAR logo

ALLY is Expanding the LACS Market – and Your Practice Can Grow With Us

LENSAR is the only company who has gained share over the last three years and is contributing to the growth of the LACS market now at nearly 14% of all IOL procedures performed.¹,²

ALLY Helps First-Time Laser Practices Enter LACS and First-Generation Laser Users Increase Volume

Whether adopting laser cataract surgery for the first time or seeking greater efficiency, surgeons are choosing ALLY® to perform more procedures with confidence.

First-time laser practices represented half of installs and/or contracted systems in Q4 2025.³ Surgeons new to laser cataract surgery find ALLY provides an advanced platform that simplifies workflow and expands premium procedure opportunities.

First-generation laser practices see ALLY improves efficiency. In fact, each ALLY System averaged 624 procedures per year compared to the industry average of 496 -that's 26% more procedures per laser than competitive lasers.⁴ 

Why Surgeons are Choosing ALLY

  • Robotic precision: Leverages the power of robotics to provide the most advanced cataract procedure available
  • Small footprint: Enables flexible workflow integration, including sterile procedures, and eliminates the need to transfer beds
  • IntelliAxis Refractive Capsulorhexis®: Marks the axis of astigmatism on the capsule, eliminating the need for manual ink marking (at each surgeon’s discretion) and reliance on scope overlays
  • Cyclotorsion compensation: Adds to precision of laser LRIs and IntelliAxis® markings
  • System efficiency: Supports a large clinical benefit with nominal workflow disruption (laser procedures completed in <60 seconds)
  • Custom fragmentation: Expedites phacoemulsification time and subsequent energy released into the eye

ALLY empowers surgeons to do more, fueling practice growth.

Learn How to Grow Your 

Premium Practice with ALLY!

LENSAR logo

1.Market Scope Ophthalmic Market Trends: Quarterly US Cataract Edition Q3 2025, Q4 2025, and Q1 2026.

2.Market Scope Ophthalmic Market Trends: Quarterly US Cataract Edition Q1 2026 and Q1 2023.

3.Data on file. LENSAR, Inc. December 31, 2025.

4.2025 Cataract Surgical Equipment Market Report. Market Scope. July 2025.

© 2026 LENSAR, Inc. All rights reserved. LENSAR, the LENSAR logo, Streamline, IntelliAxis, IntelliAxis Refractive Capsulorhexis, ALLY, the ALLY logo, ALLY Robotic Cataract Laser System, the ALLY Robotic Cataract Laser System logo and ALLY Robotic Laser Cataract Surgery are registered trademarks and Intelligent Incisions, Adaptive Intelligence, Robotic Laser Cataract Surgery, and the Robotic LCS logo are trademarks of LENSAR, Inc. All other trademarks are the property of their respective owners.